Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T13:31:46.794Z.
Calculation as of: 2026-10-06T13:31:46.794Z.
Quote observation: 2026-10-06T13:30:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.72B
EV/FCF Ratio
N/A
TTM Avg
126.26x
3Y Avg
66.65x
5Y Avg
66.65x
Market Cap
$1.84B
EV/FCF Ratio
15.27x
TTM Avg
17.23x
3Y Avg
28.18x
5Y Avg
30.02x
Market Cap
$1.74B
EV/FCF Ratio
N/A
TTM Avg
6.04x
3Y Avg
6.04x
5Y Avg
6.04x
Market Cap
$1.85B
EV/FCF Ratio
27.28x
TTM Avg
33.52x
3Y Avg
48.28x
5Y Avg
46.71x
Market Cap
$1.71B
EV/FCF Ratio
26.49x
TTM Avg
43.76x
3Y Avg
32.49x
5Y Avg
29.03x
Market Cap
$1.85B
EV/FCF Ratio
N/A
TTM Avg
34.54x
3Y Avg
34.54x
5Y Avg
34.54x
Market Cap
$1.89B
EV/FCF Ratio
N/A
TTM Avg
539.27x
3Y Avg
437.29x
5Y Avg
621.70x
Market Cap
$1.68B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.79B | N/A | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | N/A | 126.26x | 66.65x | 66.65x |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 15.27x | 17.23x | 28.18x | 30.02x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | N/A | 6.04x | 6.04x | 6.04x |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.85B | 27.28x | 33.52x | 48.28x | 46.71x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 26.49x | 43.76x | 32.49x | 29.03x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.85B | N/A | 34.54x | 34.54x | 34.54x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | N/A | 539.27x | 437.29x | 621.70x |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.68B | N/A | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.67B | N/A | 14.99x | 23.02x | 23.02x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
